BIOGRAPHY : Dr. Chong Pan Pan holds a Bachelor of Science (Hons) in Microbiology, a Master of Science in Biochemistry, and a Ph.D. in Tissue Engineering. Following the completion of her doctoral training, she served as a Postdoctoral Research Fellow before being appointed as a Senior Lecturer at the National Orthopaedic Centre of Excellence in Research and Learning (NOCERAL), Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya (UM), Malaysia. Dr. Chong is actively involved in translational orthopaedic and regenerative medicine research, with a particular emphasis on tissue engineering and orthobiologic therapies. She has played a key role in the development and clinical translation of platelet-derived extracellular vesicle (P-EV)–based therapies, which have been implemented as clinical services for musculoskeletal conditions such as lateral epicondylitis, plantar fasciitis, osteochondral defects, delayed union, and knee osteoarthritis at the University Malaya Medical Centre (UMMC) and University Malaya Specialist Centre (UMSC). Her research interests focus on adult mesenchymal stem cells (MSCs) and their application as biological therapies for poorly regenerating tissues, particularly articular cartilage. Her work investigates MSCs derived from bone marrow, peripheral blood, and adipose tissue, with an emphasis on directing chondrogenic differentiation for cartilage repair and joint regeneration in patients affected by trauma or degenerative joint diseases such as osteoarthritis. Dr. Chong has published extensively in high-impact, Q1 peer-reviewed journals and has presented her research at numerous international scientific conferences. In recognition of her contributions, she has received multiple prestigious awards, including Young Investigator Awards, Young Investigator Best Paper Award, L’Oréal Malaysia for Women in Science, as well as Best Poster and Oral Presentation awards and competitive travel fellowships. She has also actively participated in biotechnology exhibitions and innovation-driven business competitions, earning several innovation awards for her work on MSC- and P-EV-based regenerative therapies. In addition, Dr. Chong has successfully developed and secured intellectual property, with patents granted for her novel innovations in regenerative medicine and orthobiologic therapies.

Dr. Ali Ali Gobaili Saged is a Senior Lecturer at Department Quran and Hadith, Academy of Islamic Studies, University of Malaya. He was born in Sana'a, Yemen, on January 1, 1978. Previously, He worked as Traditional Healer of Islamic Medicine at Yemen with experienced for 10 years.  

Dr Nortina Shahrizaila graduated from University of Nottingham Medical School in 1997. She completed her neurology training and doctorate degree in the UK before returning to Malaysia in 2009.  She is Professor of Neurology and Consultant Neurologist at Universiti Malaya in Kuala Lumpur. She has subspecialty clinical and research interests in the field of neuromuscular disorders, including motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) and inflammatory neuropathies. She leads the multidisciplinary MND/ALS clinic at Universiti Malaya Medical Centre. She has served as Secretary of the International Federation of Clinical Neurophysiology (2022-2024) and is currently the President of the Pan-Asian Consortium for Treatment and Research in ALS (PACTALS)